Showing results (1-10 of 37) with videos related to
Sort By:
Pageof 4
STAR Protocols|June 15, 2025
Protocol for evaluating compound uptake and RNase L co-localization in live cells using fluorescence-based binding, competition assay, and confocal microscopyElias Khaskia, Raphael I BenhamouHeliyon|January 20, 2025
Leveraging RIBOTAC technology: Fluorescent RNase L probes for live-cell imaging and function analysisElias Khaskia, Raphael I BenhamouAdvanced Science (Weinheim, Baden-Wurttemberg, Germany)|October 6, 2025
RNA G-Quadruplex RIBOTAC-Mediated Targeted Degradation of lncRNA TERRAElias Khaskia, Dipak Dahatonde, Raphael I BenhamouJACS Au|August 29, 2025
Druglike Molecular Degraders of the Oncogenic RNA-Binding Protein HuRLiann Kassabri, Raphael I BenhamouNon-Coding RNA|March 25, 2024
Targeting MicroRNAs with Small MoleculesKisanet Tadesse, Raphael I BenhamouExpert Opinion on Drug Discovery|June 12, 2023
Targeted Degradation of Structured RNAs via Ribonuclease-Targeting Chimeras (RiboTacs)Salma Haj-Yahia, Arijit Nandi, Raphael I BenhamouChemistry (Weinheim an Der Bergstrasse, Germany)|June 4, 2016
Antifungal Imidazole-Decorated Cationic Amphiphiles with Markedly Low Hemolytic ActivityRaphael I Benhamou, Kfir B Steinbuch, Micha FridmanExpert Opinion on Drug Discovery|April 6, 2025
Advancing target validation with PROTAC technologyM Leora Spitz, Aseel Kashkush, Raphael I BenhamouAngewandte Chemie (International Ed. in English)|March 26, 2018
Localizing Antifungal Drugs to the Correct Organelle Can Markedly Enhance their EfficacyRaphael I Benhamou, Maayan Bibi, Judith Berman, et al.ACS Pharmacology & Translational Science|September 19, 2025
Development of PROTAC-Based Strategies for Cannabinoid Receptor Type 1 (CB1R) Degradation in CancerAseel Kashkush, Kisanet Tadesse, Judith Furth-Lavi, et al.Pageof 4